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Abstract 
BACKGROUND: Sickle Cell Disease (SCD) causes chronic haemolysis which is a risk factor for cholelithiasis. 
AIM: To determine the prevalence and clinical correlates of cholelithiasis in SCD patients in steady state treated 
at the University of Calabar Teaching Hospital. 
METHODS: This was a prospective study that took place at the Haematology and sickle cell disease clinics, 
University of Calabar Teaching Hospital, Calabar, Nigeria between January and June 2018. The study population 
were aged between 1.5-5.5 years and confirmed to have SCD through haemoglobin electrophoresis. A brief 
history was obtained, and all the patients had a physical examination. Ultrasound examination was performed 
using a B-mode mind-ray ultrasound machine using a 3.5-5.0 MHz probe after an overnight fast. A Calculus is 
diagnosed when a highly echogenic structure casting a concrete shadow is detected in the lumen of the 
gallbladder. 
RESULTS: One hundred and twenty confirmed SCD patients aged between 1.5-55 years were recruited in the 
study, 69 (57.5%) were males, while 51 (42.5%) were females. The overall prevalence of cholelithiasis was 10%, 
and it increased with age. The youngest patient with cholelithiasis was 13 years old. All the patients were 
asymptomatic at the time of examination. At the multivariate level, age, gender, weight and gallbladder volume 
were associated with gallbladder stones. 
CONCLUSION: The prevalence of cholelithiasis in patients treated at the Sickle Cell Clinic at the University of 
Calabar Teaching Hospital, Calabar is fairly high. The patients were largely asymptomatic, and cholelithiasis is 
more common in females than males. This study showed a weak association between blood transfusion and 
gallbladder stone. It is recommended that routine abdominal ultrasound scan for gallbladder be done for SCD 
patients from the second decade of life in our environment 
 
 
 
 
 
 
 
Introduction 
 
Sickle cell disease (SCD) is the commonest 
haemoglobinopathy in people of African racial origin 
[1].
 
Sickle cell haemoglobin (HBS) has its highest 
prevalence in West Africa where it is reported to have 
originated and is also present in black Americans of 
African descent, Indians and those from the eastern 
Mediterranean region [2] [3] [4]. Nigeria by her 
population is the most sickle cell disease (SCD) 
endemic country in the world with over 40 million 
people (30% of its population) being carriers of the 
haemoglobin `s` gene while the homozygous SS is 
found in about 3% of the population [5]. 
Sickle cell disease (SCD) can occur as a 
homozygous form (HbSS) or heterozygous form, such 
as HbSC or HbSD among other variants. However, 
the homozygous variant HbSS has the severest 
clinical manifestation [6] [7] [8]. 
Cholelithiasis is a frequent complication of 
chronic haemolysis due to sickle disease [9]. It is 
sometimes revealed by digestive symptoms difficult to 
distinguish from painful abdominal vaso-occlusive 
crises (recurrent abdominal pain sometimes similar to 
biliary colic, nausea, vomiting). However, cholelithiasis 
is often asymptomatic and can lead to serious 
complications (cholecystitis, cholangitis, pancreatitis, 
septicaemia starting in the bile) which can jeopardise 
patients` lives [10] [11].  
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Many studies show that the prevalence of 
cholelithiasis in patients with sickle cell disease 
increases with age and affects 6% of patients before 
15 years of age and more than 50% of young adults 
[9] [12] [13]. It is thought that the prevalence of 
cholelithiasis is substantially lower in African patients 
than Jamaican or north American patients [14]. This 
difference is attributed to differences in dietary 
cholesterol and/or fibre, but other factors (genetic or 
environmental) could have an influence. Gallstones 
treatment is equivocal, but most studies recommend 
cholecystectomy in the symptomatic cases and 
regular ultrasonography in other cases [11] [15]. 
Although there have been reports of the use 
of ultrasound in the diagnosis of cholelithiasis, the 
clinical correlates of cholelithiasis in the people with 
SCD is under-reported [9] [16]. Unlike most of the 
modern imaging modalities, ultrasound provides a 
widely available, non-invasive, inexpensive method for 
evaluating the gallbladder without the use of ionising 
radiation [17]. These factors are of particular 
importance in young patients with chronic diseases 
who require recurrent follow-up imaging. An 
ultrasound scan can be performed on routine clinic 
visits as it provides accurate pre-treatment diagnosis 
essential to plan appropriate management of this 
pathology. 
This study was designed to sonographically 
determine the prevalence and clinical correlates of 
gallbladder stones in patients with sickle cell disease 
in southern Nigeria. 
 
 
Subjects and Methods 
 
This was a prospective study carried out to 
determine the prevalence and clinical correlates of 
gallbladder stones in patients with homozygous sickle 
cell disease in southern Nigeria, between January 
2018 and April 2018. During the study period 120 
patients between the ages of 1.5-55 years attending 
the sickle cell clinics (both children and adult) at the 
University of Calabar Teaching Hospital, Calabar, 
Nigeria were consecutively recruited into the study. A 
brief history was taken with emphasis on some blood 
transmissions, number and type of crises, chronic 
abdominal pain and nature of stools. Weight and 
height of participants were documented. 
All the patients had a physical examination 
including anthropometry, under conditions of privacy 
with the following being examined: 
General examination for pallor, jaundice and 
clubbing as well as digestive system examination 
were carried out with emphasis on organ enlargement 
(liver and spleen), tenderness and Murphy’s sign. 
Ultrasound examination was performed on all 
the SCD patients without a history of 
cholecystectomy. All patients were examined with a B-
mode MINDRAY ultrasound machine using a 3.5-5.0 
MHz probe after an overnight fast. The examination 
was performed in supine and decubitus positions on a 
couch. Calculi were diagnosed when highly echogenic 
structures with acoustic shadowing were detected in 
the lumen of the gallbladder.  
Informed consent was obtained from all 
participants and strict confidentially ensured. Ethical 
clearance was obtained from the Research Ethics 
Committee of UCTH Nigeria. 
Those excluded from the study were SCD 
patients who had any other coexisting morbidities like 
HIV or malignancies, SCD patients with a history of 
cholecystectomy and SCD patients who did not give 
consent for the examination. 
The data were analysed with the Statistical 
Package for Social Sciences (SPSS) software version 
18 for the window. Simple proportions, percentages 
and graphs were used to analyse the data. Chi-square 
test was used to test the difference between 
categorical variables. Student’s t-test was used to 
compare continuous variables. Odds ratio and 
multiple regression analysis were used to identify 
predictors of gallbladder stones, a p-value of < 0.05 
was regarded as significant. 
 
 
Results 
 
One hundred and twenty confirmed sickle cell 
disease patients were recruited into the study. The 
age range of the study group was between 1.5 to 55 
years with a median age of 14.5 years; IQR 6-25years 
(Figure 1). There was a slight male preponderance; 
69(57.5%) were males, while 51(42.5%) were females 
(male: female ratio of 1.3:1). The mean age for 
females was 18.4 ± 12.3 years (95% CI 14.9-21.9 
years). The mean age for males was 14.6 ± 11.0 
years (95% CI 12.0-17.2 years). The males were 
slightly younger than the females (t = 1.8; p = 0.03). 
Cholelithiasis was reported in 12 patients 
giving a general prevalence of gallbladder calculi as 
10.0% (95% CI 5.3-16.8%). No individual had 
developed gallbladder calculi in the first 10 years of 
life. The youngest SCD patient with gallbladder calculi 
was 13 years old.  
At the univariate level, increasing age was 
significantly associated with the prevalence of gall 
bladder stones (OR = 15.17; p = 0.0001). Gender had 
no effect (x
2
 = 0.47; p = 0.50). Weight showed a trend 
(OR = 2.8; p = 0.09; 95% CI 0.99-1.04). Height was 
significantly associated with gall bladder stone (OR 
1.02, p = 0.04, 95% CI 1.00-1.05). 
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The body mass index (BMI) had no 
association with gallstones (OR = 1.06; p = 0.17; CI = 
0.98-1.14). 
 
Figure 1: Line graph showing the prevalence of gall Stones with age 
 
At the multivariate level age, gender, weight 
and gallbladder volume were associated with 
gallbladder stones (table). Area under the ROC curve 
was 0.96, indicating a very good model. No subject 
had positive Murphy’s sign. 
Table 1: Logistic Regression Model for Predictors of 
Cholelithiasis in SCD Patients 
VARIABLE 
UNIVARIATE ANALYSIS 
ODDS RATIO (95% CI, p-
VALUE) 
 
MULTIVARIATE ANALYSIS 
ODDS RATIO (95% CI, p-
VALUE) 
 
Age  1.10 (1.04 – 1.17, 0.001) 1.18(1.05 – 1.33, 0.010) 
Gender 1.54(0.44 – 5.42, 0.50) 11.77(1.02 –1.34, 0.05) 
Weight 1.02(0.99 – 1.04, 0.09) 0.90(0.82 – 0.99, 0.03) 
Height 1.02(1.00 – 1.04, 0.04) 0.99(0.98 – 1.02, 0.97) 
Number of blood 
transfusion 
1.40(1.00 – 1.96, 0,05) 1.22(0.76 – 1.98, 0.40) 
Gall bladder volume 1.03(1.012 – 1.03, 0.00) 1.04(1.01 – 1.06, 0.00) 
Liver span 1.45(1.09 – 1.90, 0.01) 1.50(0.87 – 2.44, 0.15) 
Area under ROC curve = 0.9567. 
 
 
Discussion 
 
Chronic haemolysis with its accelerated 
bilirubin turnover leads to a high incidence of pigment 
gallstones, and gallbladder sonography has become 
the dominant method of examining the gallbladder 
[18] [19] [20]. This is so because ultrasonography is 
convenient, safe and does not use ionising radiation. 
It has 88% sensitivity and 80% specificity for the 
diagnosis of gallstones [21].
 
Previous studies on the prevalence of 
cholelithiasis on SCD patients show a wide variation 
in the prevalence [12] [22] [23] [24]. The prevalence of 
cholelithiasis is reported to be substantially lower in 
African patients than in Jamaican or North American 
patients.
14
This difference could be attributed to 
differences in dietary cholesterol and/or fibre, but 
other factors (genetic or environmental) could have an 
influence.  
 
Figure 2: Cholelithiasis in a 32-year-old female SCD patient 
 
In this study, the overall prevalence of 
gallstones was 10%. The low prevalence of 
cholelithiasis compared to other studies such as that 
reported by Agholor CA et al., [16] who reported 
16.0% among 150 patients aged between 10 months 
and 51 years and Durosimi MA et al., [25] who 
documented 24.2% among 18 to 56 years old 
Nigerians with SCD could be attributable to dietary 
factors and access to specialized care. A low 
prevalence of cholelithiasis of 6% in patients younger 
than 15 years who were examined by oral 
cholecystography was reported by Akinyanju and 
Ladapo in Ibadan, Nigeria [12]. This is similar to the 
5% prevalence of cholelithiasis observed 
byAkamaguna et al., [26] among sickle cell disease 
patients at the University of Benin Teaching Hospital 
Nigeria using oral cholecystography and the 50% 
reported by Odunvbun ME et al., in a study population 
of 101 aged 1-18years.  
The prevalence of gallstones is usually 
increased with increase in age, and by the age of 18 
years, 30% of SCD are expected to have developed 
gallstones [27] [28]. The youngest SCD patient with 
gallbladder calculus was 13 years old. This finding 
was at variance with the study by Akamaguna et al., 
who reported 5.5-year-old boy as the youngest with 
gallbladder stones and the study by Odunvbun et al., 
[29] reported the youngest child with gallstones to be 
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5 years old. A Ghanaian study reported gallstone in a 
2.5-year-old SCD child [22], who was symptomatic. 
The high age of onset of gallbladder stone in our 
study may be attributed to dietary and environmental 
factors. Age, gender, weight and gallbladder volume 
are predictors in this study. This trend was also 
reflected in other studies when they were categorised 
into age groups [24] [30] [31] [32]. 
This study showed a weak association 
between blood transfusions and gallbladder stones 
and no association with chronic abdominal pain, 
gallbladder wall thickness and change in bowel habit. 
We studied patients in the steady state and patients 
with gallstones in this study were asymptomatic. This 
finding is the same as what has been reported by 
Barrett-Connor [30], Webb et al., [23] and Attalla et 
al., [22] where most their patients were asymptomatic. 
While Sarnaik [28], Cameron et al., [32] Karayalcin 
[33], and Bond et al., [24] reported that symptoms of 
typical biliary tract disease were common in patients 
with gallstones. 
With the earliest incidence of gallstones seen 
in a 13-year-old in this study, routine screening with 
abdominal ultrasound scan is recommended for 
people with SCD from the second decade of life for 
early diagnosis and treatment to prevent 
complications.  
In conclusion, the prevalence of cholelithiasis 
in patients treated at the sickle cell clinic at the 
University of Calabar Teaching Hospital, Calabar (1 m 
10%). The patients were largely asymptomatic. It 
increases with increasing age, weight, gallbladder 
volume, and is more common in females than in 
males. It is recommended that routine abdominal 
ultrasound scan for gallbladder be done for sickle cell 
patient from the second of life in our environment, 
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